Abstract. Cancer cells in ascites are usually exposed to a hypoxia tumor microenvironment and utilize enhanced glycolysis which produces energy and metabolizes nutrients to support proliferation. Vesicular stomatitis virus (VSV) is an oncolytic virus that relies on the host cellular metabolism for replication. We tested the efficacy of VSV on peritoneal carcinomatosis and assessed VSV replication in cancer cells from ascites. BALB/c female mice bearing peritoneal H22 or MethA cells received an i.p. administration of 1x10 8 PFU VSV or 1x10 8 PFU equivalent of UV-inactivated VSV on day 10, 12 and 14 after incubation. Administration of VSV resulted in a significant inhibition of ascites formation and prolonged survival of the treated mice. The replication of VSV was obviously enhanced in the cancer cells from the ascites. Considering the central carbon metabolic pathways, cancer cells in the malignant ascites provided more exogenous glucose, glutamine and pyruvate after VSV infection due to its unregulated glycolytic activity and glutamine metabolism. Pharmacologically, inhibition of the glycolytic pathway and glutamine metabolism reduced VSV replication, and this inhibited replication was rescued by the addition of multiple tricarboxylic acid (TCA) cycle intermediates. Our results demonstrated that metabolic adaptive processes in peritoneal carcinoma, such as high glycolytic activity and glutamine metabolism, favor VSV replication. These results suggest the clinical potency of VSV in the treatment of malignant ascites and provide new insights into the further exploration of the potential application of VSV in the treatment of hypoxia ascites cancer cells.
IntroductionCancer cells in ascites fluid are known to grow under highly anaerobic conditions. Previous research has shown that pO 2 in animal or patient malignant ascites is very low (1-3). Established tumor cells in ascites grow under highly crowded, virtually anoxic conditions (4-6). Under a hypoxic condition, cancer cells develop an efficient adaptive metabolic response to ensure their survival and proliferation. Glutamine and glucose represent the two main carbon sources for mammalian cells. In hypoxic cancer cells, glucose uptake and glycolytic activity are upregulated to produce pyruvate, which is then converted into lactate instead of being oxidized via the tricarboxylic acid cycle and oxidative phosphorylation (OXP HOS) (7). More recently, it has been shown that hypoxic cancer cells also exhibit an elevated glutamine demand and utilization to support cell proliferation through a glucose-independent tricarboxylic acid (TCA) cycle pathway (8-10). Cancer cells in malignant ascites favor a switch to glucose and glutaminedependent anaerobic metabolic pathways, allowing adaptation to this microenvironment and promoting growth.Viruses are dependent on the metabolic machinery of the host cell to supply the energy and molecular building blocks needed for genome replication, viral protein synthesis and membrane production. Extensive reprogramming of central carbon...